Benchmark Maintains Buy on Imax, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 75.5%

Neg 0% Neu 0% Pos 75.5%

Benchmark analyst Mike Hickey maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $44 to $60.

Comments

No comments yet. Be the first!